Skip to main content
Premium Trial:

Request an Annual Quote

PATENT WATCH: Oct 5, 2001

Premium

Xtrana, of Denver, has received US Patent Number 6,291,166, “Nucleic acid archiving.” The patent covers an invention for binding a nucleic acid to a solid substrate that is hydrophobic and electropositive. The binding process would allow the capture of nucleic acids from specimens that involve low concentrations of the nucleic acid in a high volume of sample, and enable for washes, buffer changes, and volume reductions; as well as the addition of an enzyme. The invention is designed for both research and clinical applications.

 

Applera, formerly PE Corporation, of Foster City, Calif., has received US Patent Number 6,296,702, “Apparatus and method for spotting a substrate.” This invention provides a method for spotting a small volume of liquid onto a substrate such as a microarray using a tube that is specially adapted for the liquid. The tube, which has a diameter less than 1 millimeter at its lower end, includes a long fiber within it that, when raised and lowered, deposits the liquid. The device can be adapted for high-density microarrays. The invention also includes a control unit that is connected to the positioning device for the tube. One version of the invention includes multiple tubes for deposition of multiple liquids simultaneously on different regions of the substrate.

 

Agilent Technologies has been awarded US Patent Number 6,296,452, “Microfluidic pumping.” The invention covers a method for pumping liquid through a microfluidic device. This apparatus includes a pulse jet that is activated by electrical pulses. The first pulse of the pulse jet causes pressure to be reduced at the opening to a capillary or chamber, loading the sample. A second pulse jet oriented in the opposite direction discharges the fluid from the chamber or capillary. The first opening and the pulse jet can be isolated from one another through a fluid or air barrier.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.